Aphria International will focus on expanding the Company’s footprint in established regulated cannabis markets outside of Canada.
For more information, visit: www.aphria.ca, For media inquiries please contact: Aphria will rename its recently-acquired subsidiary Nuuvera as Aphria International, remaining as a wholly-owned subsidiary of Aphria. 416-268-7099. Aphria’s existing assets and interests in Australia will also be managed under Aphria International. Aphria will now be able to enjoy the difference between the wholesale price the Company would have sold to Nuuvera and the retail margin that Nuuvera was going to sell for in Canada and internationally. andrew.swartz@aphria.com On March 23, 2018, Aphria and Nuuvera announced the successful completion of the arrangement, under which Aphria acquired, among other things, all of the common shares of Nuuvera not already owned by the Company. Copyright © 2020 CNW Group Ltd. All Rights Reserved. Located in Leamington, Ontario, the greenhouse capital of Canada, Aphria is truly powered by sunlight allowing for the most natural growing conditions available. “Today, Aphria is affirming its place as a global leader in medical cannabis, with the resources and vision for sustained growth in markets around the world,” said Vic Neufeld, CEO of Aphria. All the existing international assets represent high-value opportunities for aggressive and sustained growth, including: Lorne Abony will continue to guide Aphria International and will become the Executive International Strategic Advisor to the CEO of Aphria, leading its highly-experienced international team and their efforts at building the foremost global medical cannabis provider. Aphria Inc. (NASDAQ:APHA) has a beta value of 0 and has seen 1,859,144 shares traded in the recent trading session. Aphria intends to continually reassess its plans for this facility as domestic and international markets evolve. The largest and most comprehensive premium subscription service for cannabis traders and investors since 2013. As a result of the acquisition, Nuuvera’s offtake agreements with Aphria, for a combined total of 77,000kg annually, are no longer in place. Louis Navellier believes it’s a strong buy. In Canada, Aphria will assume management of Nuuvera’s Canadian assets, including ARA-Avanti RX Analytics Inc. (. Aphria has four clear-cut advantages over most licensed marijuana producers in Canada right now.
For more information, visit: www.aphria.ca. Contributing original content and curating quality news on only the most promising cannabis companies and the most influential investors. The value of the deal at closing was $525M, including $35M of cash in Nuuvera at closing. On March 23, 2018, Aphria and Nuuvera announced the successful completion of the arrangement, under which Aphria acquired, among other things, all of the common shares of Nuuvera not already owned by the Company. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Aphria will now be able to enjoy the difference between the wholesale price the Company would have sold to Nuuvera and the retail margin that Nuuvera was going to sell for in Canada and internationally.
That number looks even better compared to the 20% gains in the overall Canadian cannabis market. It’s number one product -- Livongo for Diabetes -- has more than. Located in Leamington, Ontario, the greenhouse capital of Canada, Aphria is truly powered by sunlight allowing for the most natural growing conditions available. Readers are cautioned that the foregoing list is not exhaustive. APHRIA INC-TS (TSE:APH)’s stock price fell 3.5% during trading on Monday . Fax: 1-844-427-4796 Aphria International will focus its activities on established regulated cannabis markets around the world, including where Aphria International already has significant interests. Recently-acquired Nuuvera to be renamed Aphria International Aphria International will focus on expanding the Company's footprint in established regulated cannabis markets outside of Canada. Aphria intends to continually reassess its plans for this facility as domestic and international markets evolve. Have a confidential news tip? To make matters worse, the full-year EPS loss was slightly worse than the 7-cent loss it reported in 2019. "We're excited to unite under one name Aphria's unparalleled ability to grow low-cost, high-quality cannabis at scale with Nuuvera's expansive international network, expertise and access to established medical cannabis markets. Moving to its international markets, the company’s subsidiary in Malta had received the E.U. Located in Leamington, Ontario, the greenhouse capital of Canada, Aphria is truly powered by sunlight allowing for the most natural growing conditions available. We've also strengthened our Canadian operations with access to the Maritimes, the addition of the cannabis GMP-certified Avanti lab, and reclaimed value from the offtake agreements previously in place with Nuuvera. Aphria International will focus on existing and future opportunities in established regulated international cannabis markets including, but not limited to, Germany, Italy, Spain, Portugal, Malta, Australia and Lesotho.
$10 billion? On March 23, 2018, Aphria and Nuuvera announced the successful completion of the arrangement, under which Aphria acquired, among other things, all of the common shares of Nuuvera not already owned by the Company.